Day: March 18, 2022

HEXO Reports Second Quarter 2022 Results, Embarks on Transformative Plan

Written by Customer Service on March 18, 2022. Posted in Earnings Releases And Operating Results.

Company makes significant progress on capital structure and strengthening balance sheet. This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dates May 11, 2021, to its short form base shelf prospectus dated May 7, 2021, and amended and restated on May 25, 2021.Senior Secured Convertible Note expected to be restructured via proposed strategic alliance with Tilray, providing the Company with financial and operating flexibility and up to $50 million of combined cost synergies, while preserving value for HEXO shareholders. New Management revises forecasts, market demand, production capacity, and opportunities for efficiencies and recognizes a $616 million in impairment losses;Executing multiple initiatives to optimize go-forward asset base and align with operational needs.Meaningful...

Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update

Written by Customer Service on March 18, 2022. Posted in Earnings Releases And Operating Results.

– Key anticipated catalysts in 2022 include submission of IND and/or CTA for DB-OTO and results from interim analysis from Phase 1b trial of DB-020 for cisplatin-induced hearing loss – – Research term extended under strategic collaboration with Regeneron to discover and develop gene therapies for hearing loss – – Announced AAV.104 gene therapy program for restoration of hearing in patients with stereocilin-related hearing loss – – Presented new preclinical data supporting continued progress of DB-OTO and importance of cell-selective transgene expression across gene therapy pipeline at the 45th Annual Association for Research in Otolaryngology Conference (ARO) – BOSTON, March 18, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated...

Centerra Gold Announces Temporary Suspension of Gold Doré Bar Production at the Öksüt Mine

Written by Customer Service on March 18, 2022. Posted in Public Companies.

TORONTO, March 18, 2022 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) today announced that it has temporarily suspended gold doré bar production at the Öksüt Mine due to mercury having been detected in the gold room of the adsorption-desorption recovery (“ADR”) plant. Centerra has taken several initial actions in response, including cleaning mercury from affected areas, taking steps to mitigate and prevent exposure, implementing the necessary safety protocols and protective equipment and is in the process of taking the necessary regulatory reporting steps. The Company is also evaluating several potential technical solutions to remove the mercury in the gold recovery process, including a retort and scrubbing system in the ADR plant, prior to the restart of production. Despite the temporary...

Kering: Statement in compliance with article 223-16 of the General Regulation of the French Financial Markets Authority – March 2022

Written by Customer Service on March 18, 2022. Posted in Public Companies.

Kering Société anonyme with a capital of € 498,771,664 Head office : 40, rue de Sèvres – 75007 PARIS 552 075 020 RCS PARIS March 18, 2022 Statement in compliance with article 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) Date Total Number of shares Total number of voting rights theoretical 1 Exercisable 2 March 15, 2022 124,692,916 177,586,528 176,962,317 1 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulations). 2 Excluding treasury shares stripped of voting rights. AttachmentKering – Statement Number of Shares and voting rights – 03.15.2022

MRC Global Announces First Quarter 2022 Earnings Release and Conference Call Schedule

Written by Customer Service on March 18, 2022. Posted in Public Companies.

HOUSTON, March 18, 2022 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC) will release its first quarter 2022 results on May 9, 2022, after the market closes. In conjunction with the release, the company will host a conference call, which will be webcast, on Tuesday, May 10, 2022, at 10:00 a.m. Eastern / 9:00 a.m. Central.What: MRC Global First Quarter 2022 Earnings Conference Call When: Tuesday, May 10, 2022, at 10:00 a.m. Eastern / 9:00 a.m. Central How: Via phone — Dial 201-689-8261 and ask for the MRC Global call at least 10 minutes prior to the start time, or via webcast — at http://www.mrcglobal.comA replay will be available through May 24, 2022, by dialing 201-612-7415 using passcode 13727805#. An archive of the webcast will be available shortly after the call at www.mrcglobal.com for 90 days. About...

Scatec publishes the 2021 Annual Report including an ESG performance Report

Written by Customer Service on March 18, 2022. Posted in Public Companies.

18 March 2022: The Board of Directors of Scatec ASA has approved the annual accounts for 2021, and the 2021 Annual Report including the ESG performance Report has today been published. The Annual Report includes a Subsequent event note summarising Scatec’s financial position, liabilities and insurance coverage in Ukraine. For further information, please contact:Andreas Austrell, VP IRTel: +47 974 38 686, andreas.austrell@scatec.com About ScatecScatec is a leading renewable energy solution provider, accelerating access to reliable and affordable clean energy in high growth markets. As a long-term player, we develop, build, own and operate renewable energy plants, with 3.5 GW of installed capacity across four continents today. We are targeting 15 GW of renewable capacity to be in operation or under construction by the end of 2025, delivered...

Notice of in-court restructuring proceedings of Orphazyme A/S

Written by Customer Service on March 18, 2022. Posted in Public Companies.

Orphazyme A/SCompany announcementNo. 11/2022www.orphazyme.comCompany Registration No. 32266355Copenhagen, Denmark, March 18, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a late-stage biopharmaceutical company, announces that following the Company’s filing of a petition for an in-court restructuring (in Danish rekonstruktion) of Orphazyme on March 10, 2022 (please see company announcement no. 10/2022), the Danish Maritime and Commercial High Court (the “Court”) has commenced the restructuring proceedings of the Company on March 11, 2022 at 7:00 am (CET). The Court has appointed attorney John Sommer Schmidt as restructuring administrator. The restructuring administrator has sent a notice of commencement of in-court restructuring proceedings of Orphazyme to all known creditors in accordance with section 11 b of...

Tautachrome (OTC:TTCM) Eyes Dual Listing

Written by Customer Service on March 18, 2022. Posted in Public Companies.

ORO VALLEY, Ariz., March 18, 2022 (GLOBE NEWSWIRE) — Tautachrome (OTC:TTCM) eyes a dual listing as project development milestones are reached. Tautachrome securities have traded on the OTC Markets since closing the 2015 merger, while development work on the company’s intellectual and proprietary technology has taken place. In late February the company began expanding corporate development areas starting with integrity defense actions. Through this process the stability of the company’s public traded securities on OTC Markets came under review. Former advancement official, Micheal Nugent, opened dialogue with the board of directors to investigate a dual listing adding Tautachrome securities as trading instruments to a full auction exchange, aiming to gain transparency in trades reflecting actual interest sentiment in the security. OTC...

Bufab Group: Notice of the Annual General Meeting of Bufab AB (publ)

Written by Customer Service on March 18, 2022. Posted in Public Companies.

The shareholders in Bufab AB (publ), Reg. No. 556685-6240, are hereby invited to attend the Annual General Meeting, which will be held on Thursday 21 April 2022, at 10.30 a.m., at Vandalorum, Skulpturvägen 2, Värnamo. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Annual General Meeting also by postal voting in accordance with the regulations in Bufab’s Articles of Association. A. RIGHT TO ATTEND THE ANNUAL GENERAL MEETING A.1 Participation in the meeting roomShareholders who intend to attend the meeting room in person or through a representative must:be registered in the register of shareholders as maintained by Euroclear Sweden AB on Monday 11 April 2022; and notify the Company of their intention to participate no later than on Wednesday 13 April 2022, by mail to Bufab...

The Ensign Group, Inc. Declares Quarterly Dividend of $0.055 Per Share

Written by Customer Service on March 18, 2022. Posted in Public Companies.

SAN JUAN CAPISTRANO, Calif., March 18, 2022 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before April 30, 2022, to shareholders of record as of March 31, 2022. Ensign has been a dividend-paying company since 2002. About Ensign™ The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 250 healthcare...

Day: March 18, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice